Published in Br Med J (Clin Res Ed) on June 19, 1982
The interferons. Clin Exp Immunol (1983) 1.22
Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother (1984) 1.11
Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. Thorax (1991) 1.11
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers. Antimicrob Agents Chemother (1985) 1.01
Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. Antimicrob Agents Chemother (1983) 0.94
Decoding the complexity of type I interferon to treat persistent viral infections. Trends Microbiol (2013) 0.90
Human lymphoblastoid interferon in the treatment of small cell lung cancer. Br J Cancer (1983) 0.88
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Adv Drug Deliv Rev (2014) 0.87
Cold comfort for the catarrhal child. Arch Dis Child (1990) 0.75
The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection (1985) 0.75
Interferon therapy and immunity. J R Soc Med (1983) 0.75
Work of a district ethical committee. Br Med J (1979) 3.64
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
A monoclonal antibody for large-scale purification of human leukocyte interferon. Nature (1980) 2.94
Large-scale production of human leukocyte interferon containing 10(8) units per ml. J Gen Virol (1978) 1.72
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Distribution and removal of human serum albumin-technetium 99m instilled intranasally. Br J Clin Pharmacol (1976) 1.52
Immunoradiometric assay of human leukocyte interferon using monoclonal antibody. Nature (1981) 1.11
Antiviral activity of intranasally applied human leukocyte interferon. Antimicrob Agents Chemother (1978) 1.06
Human nasal epithelial cell culture system: evaluation of response to human interferons. Infect Immun (1977) 1.02
Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans. J Clin Microbiol (1976) 1.01
Failure of human fibroblast interferon to protect against rhinovirus infection. Arch Virol (1980) 0.84
Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol (1979) 10.51
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J Immunol (1978) 5.35
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Enucleation of mammalian cells with cytochalasin B. Exp Cell Res (1972) 3.83
Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature (1980) 3.78
Work of a district ethical committee. Br Med J (1979) 3.64
Centrosome defects and genetic instability in malignant tumors. Cancer Res (1998) 3.32
Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child (2000) 3.28
Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet (1986) 3.14
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Analysis of logistic growth models. Math Biosci (2002) 2.96
A monoclonal antibody for large-scale purification of human leukocyte interferon. Nature (1980) 2.94
Evaluation of postal detection of registrable blindness. Br J Prev Soc Med (1968) 2.83
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res (2001) 2.66
Total screening of blood donations for Australia (hepatitis associated) antigen and its antibody. Br Med J (1972) 2.65
Preventing disability and managing chronic illness in frail older adults: a randomized trial of a community-based partnership with primary care. J Am Geriatr Soc (1998) 2.62
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, and HIV risks. AIDS Patient Care STDS (2001) 2.47
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. J Mol Biol (1974) 2.14
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Production of interferon by human leukocytes in vitro. Ann Med Exp Biol Fenn (1966) 2.13
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis (2000) 2.08
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
Bacterial contamination of autologous bone marrow during processing. J Hosp Infect (1996) 2.05
Further studies on the production of interferon by human leukocyte in vitro. Ann Med Exp Biol Fenn (1967) 2.04
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Glaucoma and intraocular pressure in Jamaica. Am J Ophthalmol (1969) 1.90
Molecular analysis of spontaneous somatic mutants. Nature (1977) 1.90
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res (2001) 1.90
Hepatitis B antigen (HBAg) and its antibody (HBAb) in hospital patients. J Clin Pathol (1974) 1.88
Preliminary analysis of the transmission dynamics of nosocomial infections: stochastic and management effects. J Hosp Infect (1999) 1.88
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Modulation of host response to Escherichia coli o157:H7 infection by anti-CD18 antibody in rabbits. Gastroenterology (1994) 1.85
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Differential expression of human interferon genes. Nucleic Acids Res (1984) 1.82
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
Partial purification of human leukocyte interferon on a large scale. Methods Enzymol (1981) 1.79
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Raising antibodies to human leukocyte interferon. Acta Pathol Microbiol Scand B (1975) 1.76
Genomic organization, chromosomal mapping, and promoter analysis of the mouse dentin sialophosphoprotein (Dspp) gene, which codes for both dentin sialoprotein and dentin phosphoprotein. J Biol Chem (1998) 1.73
Large-scale production of human leukocyte interferon containing 10(8) units per ml. J Gen Virol (1978) 1.72
GOITER SURVEY IN UTAH. Cal West Med (1924) 1.72
Secretion of interferon by Bacillus subtilis. Gene (1983) 1.70
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67
The independent living skills survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophr Bull (2000) 1.67
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand (1980) 1.64
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Clinical outcomes resulting from telemedicine interventions: a systematic review. BMC Med Inform Decis Mak (2001) 1.62
Human leukocyte interferon: production, purification, stability, and animal experiments. In Vitro Monogr (1974) 1.62
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. J Gen Virol (1975) 1.57
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
HIV antibody test should be a routine investigation for undiagnosed pneumonia. BMJ (1996) 1.56
Circulatory Overloading after Rapid Intravenous Injections. Br Med J (1942) 1.56
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells. Scand J Immunol (1979) 1.54
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54